10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations
Key Takeaways
- Total Body Water (TBW) constitutes 60% of adult body weight (70% in infants, 50% in elderly/females), divided into Intracellular Fluid (ICF, 40% of body weight / 2/3 of TBW) and Extracellular Fluid (ECF, 20% of body weight / 1/3 of TBW; partitioned into Interstitial Fluid [ISF, 15%] and Intravascular Fluid [IVF, 5%]).
- 0.9% Normal Saline has an osmolarity of 308 mOsm/L with supraphysiological sodium (154 mEq/L) and chloride (154 mEq/L), which causes normal anion gap hyperchloremic metabolic acidosis and renal vasoconstriction leading to reduced renal cortical perfusion and GFR.
- Balanced crystalloids (Lactated Ringer's [273 mOsm/L, 130 Na+, 109 Cl-, 4 K+, 3 Ca2+, 28 lactate] and Plasma-Lyte [294 mOsm/L, 140 Na+, 98 Cl-, 5 K+, 3 Mg2+, acetate/gluconate]) maintain physiological pH; LR is slightly hypotonic and contraindicated in traumatic brain injury (TBI) and should not be co-administered with PRBCs due to calcium chelating with citrate.
- Colloids provide oncotic expansion: 5% Albumin (COP ~20 mmHg) expands intravascular volume 1:1, while 25% Albumin (hyper-oncotic, COP ~70–100 mmHg) draws ~4–5 mL of fluid from the interstitium for every 1 mL infused; Hydroxyethyl starches (HES) carry FDA black-box warnings for nephrotoxicity (AKI/RRT) and cause acquired coagulopathy by reducing Factor VIII/vWF activity.
- Goal-Directed Fluid Therapy (GDFT) utilizes dynamic cardiopulmonary interactions (Stroke Volume Variation [SVV] >12–13%, Pulse Pressure Variation [PPV] >12–13%, and Stroke Volume rise >10% after a fluid challenge) in mechanically ventilated sinus-rhythm patients to guide volume responsiveness, outperforming static metrics like CVP and blood pressure.
10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations
Intraoperative fluid management is a fundamental competency in nurse anesthesia practice. The primary goals of intravenous fluid therapy are to maintain effective circulating intravascular volume, preserve cardiac preload and tissue perfusion, maintain normal electrolyte balance and acid-base homeostasis, and replace ongoing surgical losses without inducing tissue edema or hypervolemic glycocalyx shedding.
1. Body Fluid Compartments & The Endothelial Glycocalyx
Total body water (TBW) and its distribution across internal fluid compartments vary predictably based on age, gender, and adipose composition.
+-------------------------------------------------------------------------+
| TOTAL BODY WATER (TBW) COMPARTMENTS |
| (60% of Body Weight in 70-kg Adult) |
+------------------------------------+------------------------------------+
| INTRACELLULAR FLUID (ICF) | EXTRACELLULAR FLUID (ECF) |
| 40% Body Weight | 20% Body Weight |
| (2/3 of TBW = ~28 Liters) | (1/3 of TBW = ~14 Liters) |
| - Major Cation: K+, Mg2+ +-----------------+------------------+
| - Major Anions: Phosphates, | Interstitial | Intravascular |
| Proteins, Sulfates | Fluid (ISF) | Fluid (IVF) |
| | 15% Body Weight | 5% Body Weight |
| | (~10.5 Liters) | (~3.5 Liters) |
+------------------------------------+-----------------+------------------+
Compartment Fractions & Physiological Benchmarks
- Total Body Water (TBW):
- Adult male: $60%$ of total body weight ($0.60 \times \text{kg}$).
- Adult female: $50%$ of total body weight (lower due to higher body fat percentage).
- Full-term infant: $70 - 75%$ of total body weight.
- Premature neonate: $80%$ of total body weight.
- Elderly adult: $50 - 55%$ of total body weight (loss of lean muscle mass).
- Intracellular Fluid (ICF): $40%$ of body weight ($2/3$ of TBW, $\approx 28\text{ L}$ in a 70-kg adult). Primary intracellular cation is Potassium ($K^+$); primary intracellular anions are organic phosphates and proteins.
- Extracellular Fluid (ECF): $20%$ of body weight ($1/3$ of TBW, $\approx 14\text{ L}$ in a 70-kg adult). Primary extracellular cation is Sodium ($Na^+$); primary extracellular anion is Chloride ($Cl^-$).
- Interstitial Fluid (ISF): $15%$ of body weight ($3/4$ of ECF, $\approx 10.5\text{ L}$ in a 70-kg adult). Extravascular fluid bathing parenchymal cells.
- Intravascular Fluid (IVF / Plasma Volume): $5%$ of body weight ($1/4$ of ECF, $\approx 3.5\text{ L}$ in a 70-kg adult).
- Total Blood Volume (TBV): Plasma volume plus Red Blood Cell (RBC) volume ($\approx 2.1\text{ L}$). Average adult TBV is approximately $70\text{ mL/kg}$ in males and $65\text{ mL/kg}$ in females (total $\approx 5\text{ L}$ in a 70-kg individual).
The Endothelial Glycocalyx Layer & Revised Starling Model
The vascular endothelial luminal surface is coated with the endothelial glycocalyx, a 0.5–1.0 µm thick, negatively charged mesh of membrane-bound proteoglycans (syndecans, glypicans), glycosaminoglycans (heparan sulfate, chondroitin sulfate, hyaluronic acid), and adsorbed plasma proteins (principally albumin).
- Revised Starling Principle: Fluid filtration across intact capillaries is determined by the trans-endothelial oncotic pressure difference between the intravascular space and the subglycocalyx space (not the broad interstitial space). Because the subglycocalyx space is essentially protein-free, no physiological reabsorption of fluid occurs at the venous end of the capillary bed; filtered fluid returns to the circulation almost exclusively via lymphatic drainage.
- Glycocalyx Degradation: Hypervolemia, rapid crystalloid boluses (triggering Atrial Natriuretic Peptide [ANP] release), ischemia-reperfusion, sepsis, and surgical trauma strip the glycocalyx. Shedding increases capillary permeability, accelerates transvascular fluid extravasation, and produces diffuse tissue edema.
2. Crystalloid Solutions: Composition & Clinical Distinctions
Crystalloids are aqueous solutions of mineral salts and water-soluble molecules that freely cross capillary semipermeable membranes and distribute across the entire extracellular fluid (ECF) volume. Because the intravascular volume comprises only 20–25% of the ECF space, only 200–250 mL of every 1,000 mL of isotonic crystalloid remains intravascularly 30–60 minutes after rapid infusion, with 750–800 mL equilibrating into the interstitial space.
Electrolyte Profiles of Common Intravenous Crystalloids
| Solution | $Na^+$ (mEq/L) | $Cl^-$ (mEq/L) | $K^+$ (mEq/L) | $Ca^{2+}$ (mEq/L) | $Mg^{2+}$ (mEq/L) | Buffer / Anion (mEq/L) | Osmolarity (mOsm/L) | pH |
|---|---|---|---|---|---|---|---|---|
| Plasma (Serum Reference) | 135–145 | 96–106 | 3.5–5.0 | 4.5–5.5 | 1.5–2.5 | $HCO_3^-$ (24–28) | 285–295 | 7.35–7.45 |
| 0.9% Normal Saline (NS) | 154 | 154 | 0 | 0 | 0 | None | 308 | ~5.5 (4.5–7.0) |
| Lactated Ringer's (LR) | 130 | 109 | 4 | 3 | 0 | Lactate (28) | 273 | ~6.5 |
| Plasma-Lyte 148 / Normosol-R | 140 | 98 | 5 | 0 | 3 | Acetate (27), Gluconate (23) | 294 | 7.4 |
| 5% Dextrose in Water ($D_5W$) | 0 | 0 | 0 | 0 | 0 | Dextrose ($50\text{ g/L}$) | 252 | ~4.5 |
| 0.45% Saline ($1/2$ NS) | 77 | 77 | 0 | 0 | 0 | None | 154 | ~5.0 |
High-Yield Clinical Properties of Crystalloids
1. 0.9% Normal Saline (NS)
- Strong Ion Difference (SID) & Acid-Base Impact: Normal Saline has a Strong Ion Difference ($[Na^+] - [Cl^-]$) of $0\text{ mEq/L}$ (compared to normal plasma SID of $38-42\text{ mEq/L}$). Infusing large volumes of 0.9% NS delivers an unphysiologic chloride load, reducing plasma SID and creating a hyperchloremic normal anion gap metabolic acidosis ($pH \downarrow$, $HCO_3^- \downarrow$, $Cl^- \uparrow$).
- Renal Hemodynamics: Hyperchloremia sensed by the macula densa triggers tubuloglomerular feedback, inducing renal afferent arteriolar vasoconstriction, decreasing renal cortical blood flow, lowering GFR, and increasing the risk of acute kidney injury (AKI).
- Primary Indications: Hypochloremic hypokalemic metabolic alkalosis (e.g., severe vomiting, nasogastric suction, pyloric stenosis), hypercalcemia (promotes calciuresis), traumatic brain injury (TBI / elevated ICP), and dilution/co-administration with Packed Red Blood Cells (PRBCs).
2. Lactated Ringer's (LR)
- Composition & Metabolism: Balanced crystalloid containing $28\text{ mEq/L}$ sodium lactate. In the liver, lactate is oxidized to pyruvate and metabolized via gluconeogenesis to bicarbonate ($1\text{ mmol lactate} \rightarrow 1\text{ mmol } HCO_3^-$), consuming hydrogen ions and preventing acidosis.
- Slight Hypotonicity ($273\text{ mOsm/L}$): LR is slightly hypotonic compared to plasma osmolarity ($285-295\text{ mOsm/L}$). In patients with traumatic brain injury (TBI), cerebral ischemia, or elevated intracranial pressure (ICP), infusing large volumes of hypotonic fluids decreases serum osmolarity, driving water along the osmotic gradient into brain tissue and exacerbating cerebral edema.
- PRBC Incompatibility: LR contains $3\text{ mEq/L}$ ionized calcium ($Ca^{2+}$). Mixing LR directly with citrated blood products (PRBCs) overcomes the anticoagulant capacity of citrate, precipitating calcium-citrate chelation and microvascular clot formation within the IV infusion tubing.
3. Plasma-Lyte 148 & Normosol-R
- Composition: True balanced isotonic crystalloid ($294\text{ mOsm/L}$) matching plasma electrolyte composition with physiologic chloride ($98\text{ mEq/L}$) and physiological pH (7.4).
- Metabolism: Contains acetate ($27\text{ mEq/L}$) and gluconate ($23\text{ mEq/L}$) as bicarbonate precursors. Unlike lactate (which requires hepatic clearance), acetate is metabolized rapidly by peripheral skeletal muscle, making Plasma-Lyte the preferred balanced fluid in severe hepatic failure.
4. 5% Dextrose in Water ($D_5W$)
- Free Water Distribution: $D_5W$ is isotonic in the bag ($252\text{ mOsm/L}$). Once infused, dextrose ($50\text{ g/L} = 5\text{ g/100 mL}$) is rapidly cleared and metabolized by endogenous insulin. What remains is hypotonic free water, which distributes uniformly across all total body water compartments in proportion to their baseline volumes ($2/3$ to ICF, $1/3$ to ECF [only $1/12$ or $\approx 8.3%$ remains intravascularly]).
- Intravascular Expansion: Infusing $1,000\text{ mL}$ of $D_5W$ expands plasma volume by only $\approx 83\text{ mL}$.
- Neuroischemic Caution: Avoid in cerebral ischemia/stroke; hyperglycemia promotes anaerobic glycolysis in underperfused neurons, accumulating intracellular lactic acid and accelerating neuronal necrosis.
3. Colloid Solutions: Natural vs. Synthetic
Colloids are high-molecular-weight solutions that do not readily cross intact capillary membranes. They generate colloid oncotic pressure (COP) that retains fluid within the intravascular space.
+-------------------------------------------------------------------------+
| COLLOID CHARACTERISTICS & ONCOTIC POWER |
+---------------------+-----------------------+---------------------------+
| Solution | Oncotic Pressure | Volume Expansion Profile |
+---------------------+-----------------------+---------------------------+
| 5% Human Albumin | COP ~20 mmHg | 1:1 Intravascular (100%) |
| 25% Human Albumin | COP ~70 - 100 mmHg | 4:1 to 5:1 (400 - 500%) |
| Hydroxyethyl Starch | High initial COP | 1:1 (Nephro/Coagulopathy) |
| Dextrans / Gelatins | High COP | Anaphylaxis / Crossmatch |
+---------------------+-----------------------+---------------------------+
Clinical Comparison of Colloid Formulations
- 5% Human Albumin (Iso-oncotic):
- COP: $\approx 20\text{ mmHg}$ (matches normal plasma COP).
- Intravascular Yield: 1:1 volume expansion ($500\text{ mL}$ infused produces $\approx 500\text{ mL}$ intravascular volume expansion). Intravascular half-life is 16–24 hours when the glycocalyx is intact.
- Preparation: Heat-treated ($60^\circ\text{C}$ for 10 hours) during manufacturing, eliminating transmission risk of viral pathogens (HIV, Hepatitis B/C).
- 25% Human Albumin (Hyper-oncotic):
- COP: $\approx 70 - 100\text{ mmHg}$ (hyper-oncotic).
- Interstitial Fluid Shift: Draws $4 - 5\text{ mL}$ of water from the interstitial space into the intravascular space for every $1\text{ mL}$ infused.
- Intravascular Yield: Infusing a $100\text{ mL}$ bottle of 25% albumin expands intravascular plasma volume by $400 - 500\text{ mL}$ within 30–60 minutes.
- Indications: Severe hypoalbuminemia in volume-overloaded states, post-large-volume paracentesis ($>5\text{ L}$ removed; administer 6–8 g albumin per liter of ascites removed), and hepatorenal syndrome.
- Hydroxyethyl Starches (HES / Hetastarch / Hextend / Voluven):
- Nephrotoxicity Black Box Warning: Synthetic polymer of modified amylopectin. Accumulates in renal reticuloendothelial cells, causing osmotic nephrosis, acute kidney injury (AKI), and increased requirement for renal replacement therapy (RRT) in critically ill and septic patients.
- Acquired Coagulopathy: Coats circulating platelets (inhibiting GpIIb/IIIa activation), reduces plasma levels of Factor VIII and von Willebrand factor (vWF), and impairs clot strength (lowers TEG Maximum Amplitude).
- Dextrans & Gelatins:
- Dextran-40 & Dextran-70: Synthetic glucose polymers. Associated with severe IgE-independent anaphylactoid reactions, erythrocyte coating (which interferes with blood type and crossmatch), and acute renal failure due to tubular obstruction.
- Gelatins (Modified Bovine Collagen): High incidence of allergic/anaphylactic reactions due to histamine release.
4. Traditional Perioperative Fluid Calculations
Traditional fluid regimens rely on mathematical approximations to replace fasting maintenance, preoperative fluid deficits, and third-space tissue redistribution.
+-------------------------------------------------------------------------+
| HOLLIDAY-SEGAR 4-2-1 MAINTENANCE RULE |
+--------------------+----------------------------------------------------+
| Weight Tier | Hourly Maintenance Rate |
+--------------------+----------------------------------------------------+
| First 10 kg | 4 mL/kg/hr (0 - 10 kg = up to 40 mL/hr) |
| Next 10 kg (11-20) | 2 mL/kg/hr (11 - 20 kg = up to 20 mL/hr) |
| Each kg above 20 kg| 1 mL/kg/hr for every kg > 20 kg |
+--------------------+----------------------------------------------------+
| SHORTCUT (wt >20kg)| Weight in kg + 40 = Hourly Maintenance Rate (mL/hr)|
+--------------------+----------------------------------------------------+
The 4-2-1 Rule & Shortcut Calculation
- Formula Steps:
- $0 - 10\text{ kg}$: $4\text{ mL/kg/hr}$
- $11 - 20\text{ kg}$: $2\text{ mL/kg/hr}$
- $>20\text{ kg}$: $1\text{ mL/kg/hr}$
- Quick Calculation Method (for patients $>20\text{ kg}$):
- Example (70-kg patient): $70 + 40 = 110\text{ mL/hr}$
- Example (85-kg patient): $85 + 40 = 125\text{ mL/hr}$
Preoperative NPO Deficit & Replacement Schedule
- Replacement Fraction Schedule:
- 1st Hour of Anesthesia: $50%$ of total NPO deficit $+$ hourly maintenance $+$ surgical loss.
- 2nd Hour of Anesthesia: $25%$ of total NPO deficit $+$ hourly maintenance $+$ surgical loss.
- 3rd Hour of Anesthesia: $25%$ of total NPO deficit $+$ hourly maintenance $+$ surgical loss.
Third-Space & Surgical Tissue Trauma Losses
Third-space loss represents non-functional sequestration of fluid into traumatized interstitial tissue and evaporative loss from exposed peritoneal/pleural cavities:
- Minimal Trauma (e.g., hernia repair, laparoscopic cholecystectomy, cataract, carpal tunnel): $0 - 2\text{ mL/kg/hr}$
- Moderate Trauma (e.g., open cholecystectomy, open hysterectomy, total knee arthroplasty): $2 - 4\text{ mL/kg/hr}$
- Severe Trauma (e.g., major open exploratory laparotomy, bowel resection, Whipple procedure, open AAA): $4 - 8\text{ mL/kg/hr}$ (up to $6 - 10\text{ mL/kg/hr}$ for massive resections)
Blood Loss Replacement Ratios
- Crystalloid Replacement: $3:1$ ratio ($3\text{ mL}$ of balanced crystalloid for every $1\text{ mL}$ of estimated blood loss [EBL]) due to rapid redistribution into interstitial fluid.
- Colloid or Blood Product Replacement: $1:1$ ratio ($1\text{ mL}$ of colloid, 5% albumin, or PRBCs for every $1\text{ mL}$ of EBL).
Comprehensive Traditional Calculation Case Example: A 70-kg male undergoing an open bowel resection (severe trauma, $6\text{ mL/kg/hr}$) has been NPO for 8 hours. Estimated blood loss during Hour 1 is $100\text{ mL}$.
- Hourly Maintenance: $70 + 40 = 110\text{ mL/hr}$
- NPO Deficit: $110\text{ mL/hr} \times 8\text{ hours} = 880\text{ mL}$
- Hour 1 Deficit Replacement (50%): $880 \times 0.50 = 440\text{ mL}$
- Third-Space Loss: $70\text{ kg} \times 6\text{ mL/kg/hr} = 420\text{ mL/hr}$
- EBL Replacement (3:1 crystalloid): $100\text{ mL} \times 3 = 300\text{ mL}$ Total Hour 1 Fluid Delivery: $110\text{ (maint)} + 440\text{ (deficit)} + 420\text{ (3rd space)} + 300\text{ (EBL)} = \mathbf{1,270\text{ mL}}$.
5. Goal-Directed Fluid Therapy (GDFT) & Dynamic Hemodynamic Parameters
Modern anesthetic practice recognizes that aggressive, unguided crystalloid administration leads to tissue edema, impaired wound healing, bowel anastomotic dehiscence, prolonged postoperative ileus, and pulmonary complications. Conversely, overly restrictive fluid strategies lead to organ hypoperfusion and acute kidney injury.
+-------------------------------------------------------------------------+
| DYNAMIC VS STATIC VOLUME PARAMETERS |
+------------------------------------+------------------------------------+
| DYNAMIC PARAMETERS (High Accuracy) | STATIC PARAMETERS (Poor Accuracy) |
| - Stroke Volume Variation (SVV) | - Central Venous Pressure (CVP) |
| - Pulse Pressure Variation (PPV) | - Mean Arterial Pressure (MAP) |
| - Stroke Volume (SV) Response >10% | - Heart Rate (HR) |
| - Passive Leg Raise (PLR) | - Hourly Urine Output (UOP) |
+------------------------------------+------------------------------------+
The Physiology of Dynamic Cardiopulmonary Interactions
During positive-pressure mechanical ventilation, cyclic changes in intrathoracic pressure modulate right and left ventricular loading:
- Inspiration (Positive Pressure): Increases intrathoracic pressure $\rightarrow$ compresses vena cava and decreases venous return (decreases RV preload) $\rightarrow$ temporarily increases LV preload via pulmonary venous squeezing $\rightarrow$ peak stroke volume ($SV_{max}$).
- Expiration: Decreased RV stroke volume passes through the pulmonary circulation 2–3 beats later (pulmonary transit time), resulting in minimum LV preload and minimum stroke volume ($SV_{min}$).
Dynamic Hemodynamic Indices
- Stroke Volume Variation (SVV): Calculated by arterial pulse contour analysis:
- Normal / Non-responder: $\text{SVV} < 10 - 12%$
- Volume Responder: $\text{SVV} > 12 - 13%$ (indicates patient is operating on the steep ascending limb of the Frank-Starling curve and will increase cardiac output in response to fluid loading).
- Pulse Pressure Variation (PPV): Calculated from arterial line waveform systolic-diastolic pressure swings:
- Volume Responder Threshold: $\text{PPV} > 12 - 13%$
- Fluid Challenge / Stroke Volume Optimization: Administer a defined mini-bolus ($250\text{ mL}$ of balanced crystalloid or colloid over 5–10 minutes) or perform a Passive Leg Raise (PLR) test (autotransfuses $\approx 300\text{ mL}$ of venous blood from lower extremities). A $\ge 10%$ increase in Stroke Volume (SV) confirms volume responsiveness.
Strict Prerequisites for SVV & PPV Validity
Dynamic parameters are only valid under specific cardiopulmonary conditions:
- Controlled Mechanical Ventilation: Mandatory volume-controlled mode with Tidal Volume $\ge 8\text{ mL/kg}$ Predicted Body Weight (PBW) (low tidal volumes $<6\text{ mL/kg}$ generate insufficient intrathoracic pressure swings, causing false-negative SVV).
- Absence of Spontaneous Respiratory Efforts: Spontaneous breathing triggers negative intrathoracic pressures, corrupting cyclic waveform variation.
- Regular Sinus Rhythm: Cardiac arrhythmias (atrial fibrillation, frequent PVCs) cause beat-to-beat stroke volume variations unrelated to respiration, completely invalidating SVV/PPV.
- Closed Thorax: Open thoracotomy eliminates the enclosed intrathoracic pressure chamber.
- Normal Intra-Abdominal Pressure: Severe abdominal hypertension (e.g., high-pressure pneumoperitoneum $>15\text{ mmHg}$) artificially elevates SVV.
A 45-year-old female with normal renal function receives 4 liters of 0.9% Normal Saline during an emergent 5-hour abdominal surgery. An arterial blood gas obtained at the conclusion of the case reveals: pH 7.27, PaCO2 36 mmHg, PaO2 142 mmHg, HCO3- 16 mEq/L, Na+ 140 mEq/L, Cl- 116 mEq/L. What is the underlying acid-base disorder, and what is the primary pathophysiological mechanism responsible for this finding?
An 80-kg male is scheduled for an exploratory laparotomy with open bowel resection (estimated severe surgical trauma loss of 6 mL/kg/hr). He has been strictly NPO for 10 hours prior to induction. If the estimated blood loss during the first hour of surgery is 150 mL (replaced with balanced crystalloid at a 3:1 ratio), what is the total volume of IV crystalloid that should be administered during the first hour of anesthesia using traditional fluid formulas?
Which of the following clinical conditions and mechanical ventilator settings satisfies ALL mandatory prerequisites for accurately interpreting Stroke Volume Variation (SVV) and Pulse Pressure Variation (PPV) to predict volume responsiveness?